ES2127110A1 - Procedure for varying the electrical properties of human ocular mucus and of substitutes for ophthalmic use - Google Patents

Procedure for varying the electrical properties of human ocular mucus and of substitutes for ophthalmic use

Info

Publication number
ES2127110A1
ES2127110A1 ES09601215A ES9601215A ES2127110A1 ES 2127110 A1 ES2127110 A1 ES 2127110A1 ES 09601215 A ES09601215 A ES 09601215A ES 9601215 A ES9601215 A ES 9601215A ES 2127110 A1 ES2127110 A1 ES 2127110A1
Authority
ES
Spain
Prior art keywords
varying
procedure
electrical properties
substitutes
human ocular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09601215A
Other languages
Spanish (es)
Other versions
ES2127110B1 (en
Inventor
Juan Tomas Girbes
Jimeno Jose Carlos Pastor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Valladolid
Original Assignee
Universidad de Valladolid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Valladolid filed Critical Universidad de Valladolid
Priority to ES9601215A priority Critical patent/ES2127110B1/en
Publication of ES2127110A1 publication Critical patent/ES2127110A1/en
Application granted granted Critical
Publication of ES2127110B1 publication Critical patent/ES2127110B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedure for varying the electrical properties of human ocular mucus and of substitutes for ophthalmic use. A description is given of a new procedure for varying the charge and thus the electrical properties of human ocular mucus, which consists in varying the sialic acid content. Said procedure is useful in the manufacture of ophthalmic solutions whose electrical properties significantly determine their usefulness as eye-surface lubricants in pathological conditions, such as for example in the treatment of dry-eye syndrome, as well as their use as vehicles for pharmacologically active principles.
ES9601215A 1996-05-24 1996-05-24 PROCEDURE TO VARY THE ELECTRICAL PROPERTIES OF THE HUMAN EYE MOCO AND SUBSTITUTES FOR OPHTHALMIC USE. Expired - Fee Related ES2127110B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9601215A ES2127110B1 (en) 1996-05-24 1996-05-24 PROCEDURE TO VARY THE ELECTRICAL PROPERTIES OF THE HUMAN EYE MOCO AND SUBSTITUTES FOR OPHTHALMIC USE.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9601215A ES2127110B1 (en) 1996-05-24 1996-05-24 PROCEDURE TO VARY THE ELECTRICAL PROPERTIES OF THE HUMAN EYE MOCO AND SUBSTITUTES FOR OPHTHALMIC USE.

Publications (2)

Publication Number Publication Date
ES2127110A1 true ES2127110A1 (en) 1999-04-01
ES2127110B1 ES2127110B1 (en) 1999-12-01

Family

ID=8295005

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9601215A Expired - Fee Related ES2127110B1 (en) 1996-05-24 1996-05-24 PROCEDURE TO VARY THE ELECTRICAL PROPERTIES OF THE HUMAN EYE MOCO AND SUBSTITUTES FOR OPHTHALMIC USE.

Country Status (1)

Country Link
ES (1) ES2127110B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7528113B2 (en) 1999-11-26 2009-05-05 Adenovir Pharma Ab Method and composition for the treatment of adenoviral ocular infections

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012808A1 (en) * 1990-02-22 1991-09-05 Macnaught Pty Limited Artificial tears

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012808A1 (en) * 1990-02-22 1991-09-05 Macnaught Pty Limited Artificial tears

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BASE DE DATOS CAPLUS en STN, Chemical Abstracts Service (Columbus, OH, U.S.A.), AN: 1996:275165, Conferencia: Ocul. Toxicol. [Proc. Congr. Int. Soc. Ocul. Toxicol.], 4th, 1995. Meeting Date 1994, 269-276 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7528113B2 (en) 1999-11-26 2009-05-05 Adenovir Pharma Ab Method and composition for the treatment of adenoviral ocular infections

Also Published As

Publication number Publication date
ES2127110B1 (en) 1999-12-01

Similar Documents

Publication Publication Date Title
CA2361827A1 (en) Multifocal ophthalmic lens with reduced halo size
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
BR9910251A (en) Hematopoietic stimulation
CA2288793A1 (en) Poly(vinyl alcohol) cryogel
UA48946C2 (en) Arylalkyldiazinones, method for their preparation, pharmaceutical composition, method of its preparation and treatment method
ES2175087T3 (en) USEFUL TRICICLIC COMPOUNDS IN THE TREATMENT OF CELL PROLIFERATION DISORDERS.
SE8403090L (en) GEL FOR USE AS A GLASS BODY SUBSTITUTE
WO1998046258A3 (en) Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions
CA2154103A1 (en) Treatment of Mucous Membrane Disease, Trauma or Condition and for the Relief of Pain
CA2198706A1 (en) Methods for the treatment of inflammatory joint disease
EP0742464A3 (en) Multifocal ophthalmic lens
SE9303788L (en) Biomedical electrode
AU548758B2 (en) Angiokinase, vasal fibrinolytic active principle
EP0937460A3 (en) Use of an antidiarrheal for the manufacture of a medicament for the treatment of inflammatory conditions
AU6682594A (en) Treatment of septic shock
HK185396A (en) Bcrf1 proteins as inhibitors of interferon--g(g)
ES2127110A1 (en) Procedure for varying the electrical properties of human ocular mucus and of substitutes for ophthalmic use
WO2003049667A3 (en) The method of treating cancer
AU6808190A (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
EP0361490A3 (en) Sulfated oligosaccharides and derivatives thereof
WO1996032134A3 (en) Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body
IT1294931B1 (en) DERIVATIVES OF 2-AMINOTETHRALIN PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, ACTIVE IN THE
PT782630E (en) GENE OF THE POLITICAL DISEASE OF RIM
EP0273310A3 (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
Robinson et al. Auditory impairment and the onset of disability and handicap in noise-induced hearing loss

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990401

Kind code of ref document: A1

Effective date: 19990401

FD2A Announcement of lapse in spain

Effective date: 20160831